Sharda Cropchem Limited
Sharda Cropchem Limited Fundamental Analysis
Sharda Cropchem Limited (SHARDACROP.NS) shows strong financial fundamentals with a PE ratio of 14.53, profit margin of 11.25%, and ROE of 22.70%. The company generates $50.3B in annual revenue with strong year-over-year growth of 36.67%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 92.3/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.
Fundamental Health Score
We analyze SHARDACROP.NS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentSHARDACROP.NS demonstrates superior asset utilization.
Valuation Score
ExcellentSHARDACROP.NS trades at attractive valuation levels.
Growth Score
ModerateSHARDACROP.NS shows steady but slowing expansion.
Financial Health Score
ExcellentSHARDACROP.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateSHARDACROP.NS maintains healthy but balanced margins.
Key Financial Metrics
Is SHARDACROP.NS Expensive or Cheap?
P/E Ratio
SHARDACROP.NS trades at 14.53 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, SHARDACROP.NS's PEG of 0.58 indicates potential undervaluation.
Price to Book
The market values Sharda Cropchem Limited at 3.07 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 8.44 times EBITDA. This is generally considered low.
How Well Does SHARDACROP.NS Make Money?
Net Profit Margin
For every $100 in sales, Sharda Cropchem Limited keeps $11.25 as profit after all expenses.
Operating Margin
Core operations generate 12.32 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $22.70 in profit for every $100 of shareholder equity.
ROA
Sharda Cropchem Limited generates $11.54 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Sharda Cropchem Limited produces operating cash flow of $6.05B, showing steady but balanced cash generation.
Free Cash Flow
Sharda Cropchem Limited generates strong free cash flow of $6.05B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $67.04 in free cash annually.
FCF Yield
SHARDACROP.NS converts 7.35% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
14.53
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.58
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.07
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.63
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.001
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.78
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.23
vs 25 benchmark
ROA
Return on assets percentage
0.12
vs 25 benchmark
ROCE
Return on capital employed
0.22
vs 25 benchmark
How SHARDACROP.NS Stacks Against Its Sector Peers
| Metric | SHARDACROP.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 14.53 | 23.53 | Better (Cheaper) |
| ROE | 22.70% | 873.00% | Weak |
| Net Margin | 11.25% | -102723.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.51 | Strong (Low Leverage) |
| Current Ratio | 1.78 | 5.06 | Neutral |
| ROA | 11.54% | -6387.00% (disorted) | Strong |
SHARDACROP.NS outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Sharda Cropchem Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
116.21%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
84.87%
Industry Style: Cyclical, Commodity, Value
High GrowthFCF CAGR
312.64%
Industry Style: Cyclical, Commodity, Value
High Growth